Multimodality Imaging of Myocardial Viability

[21] Thoné F(2008)Stunning, hibernation, and assessment of myocardial viability Circulation 117 103-114

[22] Shivalkar B(2018)Myocardial viability testing to guide coronary revascularization Interv Cardiol Clin 7 355-365

[23] Flameng W(2020)State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association Circ Cardiovasc Imaging 13 e000053-1226

[24] Depré C(2016)ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures J Nucl Cardiol 23 1187-1768

[25] Vanoverschelde JL(2006)Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? J Nucl Med 47 1763-188

[26] Ramaekers F(2001)Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium Curr Probl Cardiol 26 141-3444

[27] Borgers M(1995)Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation. 92 3436-1743

[28] Cheirif J(2001)Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability Eur Heart J 22 1691-723

[29] Murgo JP(2002)Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J Am Coll Cardiol 40 1735-542

[30] Hays JT(2006)Prediction of functional recovery after revascularization in patients with chronic left ventricular dysfunction: head to head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/18F-FDG PET Eur J Nucl Med Mol Imaging 33 716-2783

[21] Thoné F(2008)Stunning, hibernation, and assessment of myocardial viability Circulation 117 103-114

[22] Shivalkar B(2018)Myocardial viability testing to guide coronary revascularization Interv Cardiol Clin 7 355-365

[23] Flameng W(2020)State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association Circ Cardiovasc Imaging 13 e000053-1226

[24] Depré C(2016)ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures J Nucl Cardiol 23 1187-1768

[25] Vanoverschelde JL(2006)Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy? J Nucl Med 47 1763-188

[26] Ramaekers F(2001)Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium Curr Probl Cardiol 26 141-3444

[27] Borgers M(1995)Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy Circulation. 92 3436-1743

[28] Cheirif J(2001)Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of(18)F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability Eur Heart J 22 1691-723

[29] Murgo JP(2002)Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function J Am Coll Cardiol 40 1735-542

[30] Hays JT(2006)Prediction of functional recovery after revascularization in patients with chronic left ventricular dysfunction: head to head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/18F-FDG PET Eur J Nucl Med Mol Imaging 33 716-2783